ClinicalTrials.Veeva

Menu

China Stroke Registry for Patients With Traditional Chinese Medicine (CASES-TCM)

D

Dongzhimen Hospital, Beijing

Status

Not yet enrolling

Conditions

Ischemic Stroke
Intracerebral Hemorrhage

Study type

Observational

Funder types

Other

Identifiers

NCT04921397
2021XS-001

Details and patient eligibility

About

The CASES-TCM study is a prospective, multicenter, observational study, which will enroll 20,000 patients with acute stroke (ischemic stroke or intracerebral hemorrhage) within 7 days of symptom onset.

This study attempts to depict major clinical characteristics of acute stroke in patients with Chinese medicine treatment and to explore any difference compared with other non-Chinese medicine use cohorts and the effectiveness and safety of Chinese medicine.

Enrollment

20,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥18 years of age
  • Diagnosed as acute ischemic stroke or intracerebral hemorrhage
  • Within 7 days of symptom onset

Exclusion criteria

  • Refusal to give informed consent
  • Have difficulties completing follow-up

Trial contacts and locations

1

Loading...

Central trial contact

Ying Gao

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems